Tossing and turning in bed all night long, it can feel as if you're the only person in the world unable to sleep. It may be a small comfort to learn, however, that you aren't the only one. Millions of other Americans also struggle to sleep.
In the latest Morbidity and Mortality Weekly Report, the CDC reports data on the prevalence of sleep trouble by age group and sex. (See chart below.)

We flipped toy and holiday season safety on its head and chose to be more proactive by focusing on how NOT to hurt kids.  Learn how here.

Does road salt turn female tadpoles into male frogs? A group from Yale says it does. We say, "Bullsalt!"

The position of Science Czar is just one of thousands that President-Elect Trump must consider in the coming weeks. The incumbent, John Holdren, was a flawed choice. His fringe views on demographics and environmental policy, expressed in a book he co-authored with Paul Ehrlich (who notoriously wrote the now discredited The Population Bomb), should have disqualified him from the post. 

The prevalence of dementia in the United States significantly declined from 11.6 percent in 2000 to 8.8 percent in 2012. The consequence of this impacts retirement, families, the health care system, life expectancy, morbidity and mortality, pensions, housing, transportation and countless societal realms. 

While it's true that statins are effective in preventing a recurrence of cardiovascular events (e.g. heart attack or stroke), the evidence that they are useful for primary prevention in older people isn't robust. Should the prescription of these drugs be extended to our expanding geriatric population, or is this an example of over-medicalization?

Florida is in the middle of a major 'not in my backyard' brouhaha at the moment and biotechnology is at the center of the debate.

Donald Trump's wall is non-stop fodder for the ceaseless political conversation surrounding the election. But, it may have some use, especially in keeping addicts alive. Even if completely useless, it is still better than our current plan of severely restricting opioid prescriptions to people who really need them.

The business plan for antibiotics is very different from that of other drugs. Our advisor, Dr. David Shlaes discusses why the absence of a viable plan in the US represents yet one more problem in an area where there are already plenty. 

Though we didn't invent Mean Tweets, we here at the council are quite familiar with the term. Enjoy nearly 4 minutes of nasty comments from some of our critics read by us... and we weren't quite kind in return.